Shehzad Z Sheikh1, Scott E Plevy. 1. Department of Medicine, Microbiology and Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina 27599, USA.
Abstract
PURPOSE OF REVIEW: The purpose of this review is to highlight macrophages as central mediators of intestinal immune homeostasis and inflammation. RECENT FINDINGS: We review recent developments elucidating distinct phenotypic adaptations in intestinal macrophages that determine their functional role in a microbe-rich environment. The involvement of intestinal macrophages in the pathogenesis of inflammatory bowel disease is also discussed. SUMMARY: Intestinal macrophages represent the largest pool of tissue macrophages in the human body and a critical interface with the enteric microbiota. In normal physiology, luminal microbes breach the intestinal epithelial barrier and gain access to the lamina propria. Bacteria are efficiently phagocytosed by macrophages strategically located underneath the epithelium. The importance of functional adaptations of macrophages to perform their role in this unique environment is best illustrated by failure of these mechanisms during the development of chronic inflammatory bowel diseases. Compared with monocytes or macrophages from any other organ, intestinal macrophages express different phenotypic markers, efficiently eradicate intracellular bacteria, but do not mount potent inflammatory responses. Converging human genetic and functional findings suggest that dysregulation of macrophage-specific immune responses against an otherwise harmless enteric microbiota are key factors in the pathogenesis of inflammatory bowel disease.
PURPOSE OF REVIEW: The purpose of this review is to highlight macrophages as central mediators of intestinal immune homeostasis and inflammation. RECENT FINDINGS: We review recent developments elucidating distinct phenotypic adaptations in intestinal macrophages that determine their functional role in a microbe-rich environment. The involvement of intestinal macrophages in the pathogenesis of inflammatory bowel disease is also discussed. SUMMARY: Intestinal macrophages represent the largest pool of tissue macrophages in the human body and a critical interface with the enteric microbiota. In normal physiology, luminal microbes breach the intestinal epithelial barrier and gain access to the lamina propria. Bacteria are efficiently phagocytosed by macrophages strategically located underneath the epithelium. The importance of functional adaptations of macrophages to perform their role in this unique environment is best illustrated by failure of these mechanisms during the development of chronic inflammatory bowel diseases. Compared with monocytes or macrophages from any other organ, intestinal macrophages express different phenotypic markers, efficiently eradicate intracellular bacteria, but do not mount potent inflammatory responses. Converging human genetic and functional findings suggest that dysregulation of macrophage-specific immune responses against an otherwise harmless enteric microbiota are key factors in the pathogenesis of inflammatory bowel disease.
Authors: G Rogler; M Hausmann; D Vogl; E Aschenbrenner; T Andus; W Falk; R Andreesen; J Schölmerich; V Gross Journal: Clin Exp Immunol Date: 1998-05 Impact factor: 4.330
Authors: John D Rioux; Ramnik J Xavier; Kent D Taylor; Mark S Silverberg; Philippe Goyette; Alan Huett; Todd Green; Petric Kuballa; M Michael Barmada; Lisa Wu Datta; Yin Yao Shugart; Anne M Griffiths; Stephan R Targan; Andrew F Ippoliti; Edmond-Jean Bernard; Ling Mei; Dan L Nicolae; Miguel Regueiro; L Philip Schumm; A Hillary Steinhart; Jerome I Rotter; Richard H Duerr; Judy H Cho; Mark J Daly; Steven R Brant Journal: Nat Genet Date: 2007-04-15 Impact factor: 38.330
Authors: Lesley E Smythies; Marty Sellers; Ronald H Clements; Meg Mosteller-Barnum; Gang Meng; William H Benjamin; Jan M Orenstein; Phillip D Smith Journal: J Clin Invest Date: 2005-01 Impact factor: 14.808
Authors: Janine L Coombes; Karima R R Siddiqui; Carolina V Arancibia-Cárcamo; Jason Hall; Cheng-Ming Sun; Yasmine Belkaid; Fiona Powrie Journal: J Exp Med Date: 2007-07-09 Impact factor: 14.307
Authors: Laura K Johnston; Cliff R Rims; Sean E Gill; John K McGuire; Anne M Manicone Journal: Am J Respir Cell Mol Biol Date: 2012-06-21 Impact factor: 6.914
Authors: Fiore Cattaruzza; Victoria Lyo; Ella Jones; David Pham; James Hawkins; Kimberley Kirkwood; Eduardo Valdez-Morales; Charles Ibeakanma; Stephen J Vanner; Matthew Bogyo; Nigel W Bunnett Journal: Gastroenterology Date: 2011-07-28 Impact factor: 22.682
Authors: Erin C Steinbach; Taku Kobayashi; Steven M Russo; Shehzad Z Sheikh; Gregory R Gipson; Samantha T Kennedy; Jennifer K Uno; Yoshiyuki Mishima; Luke B Borst; Bo Liu; Hans Herfarth; Jenny P Y Ting; R Balfour Sartor; Scott E Plevy Journal: J Immunol Date: 2014-03-14 Impact factor: 5.422
Authors: Jeremy M Simon; James P Davis; Saangyoung E Lee; Matthew R Schaner; Gregory R Gipson; Matthew Weiser; R Balfour Sartor; Hans H Herfarth; Reza Rahbar; Timothy S Sadiq; Mark J Koruda; Dermot P McGovern; Jason D Lieb; Karen L Mohlke; Terrence S Furey; Shehzad Z Sheikh Journal: Eur J Immunol Date: 2016-06-01 Impact factor: 5.532
Authors: Nair Nazareth; Fernando Magro; Rui Appelberg; Jani Silva; Daniela Gracio; Rosa Coelho; José Miguel Cabral; Candida Abreu; Guilherme Macedo; Tim J Bull; Amélia Sarmento Journal: Med Microbiol Immunol Date: 2015-02-22 Impact factor: 3.402
Authors: N Nazareth; F Magro; J Silva; M Duro; D Gracio; R Coelho; R Appelberg; G Macedo; A Sarmento Journal: Clin Exp Immunol Date: 2014-09 Impact factor: 4.330
Authors: Rohit Ramanathan; Anita Kohli; María Clara Ingaramo; Alka Jain; Sean X Leng; Naresh M Punjabi; Jeremy D Walston; Neal S Fedarko Journal: J Gerontol A Biol Sci Med Sci Date: 2013-03-22 Impact factor: 6.053